期刊文献+

奥拉西坦注射液中奥拉西坦2种含量测定方法的比较 被引量:6

Method comparison in the determination of oxiracetam injection
下载PDF
导出
摘要 目的比较奥拉西坦注射液2种不同的含量测定方法。方法分别采用凯氏定氮法和HPLC法测定奥拉西坦注射液的含量。结果凯氏定氮法测定的平均回收率为99.6%,RSD为0.3%;HPLC法测定的平均回收率为99.4%,RSD为0.3%,奥拉西坦在0.020 84~0.187 56 mg.mL-1与峰面积呈良好线性关系,r=0.999 96。结论 2种测定方法的测定结果无明显差异;凯氏定氮测定法方法简便、成本低,但专属性相对较差,可用于常规检查;HPLC法专属性强、灵敏度高、重复性好,为更好的控制样品的质量,可将HPLC法订入质量标准。 Objective To compare two methods used in the determination of oxiracetam injection.Methods The contents were determined by HPLC method and Kjeldah method.Results The average recovery for Kjeldah method was 99.6%,and RSD was 0.3%.The average recovery for HPLC was 99.4%,and RSD 0.3%.Oxiracetam showed a good linear relationship within 0.020 84-0.187 56 mg·mL-1,r=0.9999 6.Conclusion There is no significant difference in the two methods.Kjeldah method is simple,with low cost but poor speciality,so it can be used as the routine method.HPLC is exclusive,reproducible,and highly sensitive,which can be used in the quality control of oxiracetam injection.
出处 《中南药学》 CAS 2010年第11期845-847,共3页 Central South Pharmacy
关键词 奥拉西坦 高效液相色谱法 凯氏定氮法 oxiraeetam HPLC Kjeldah method
  • 相关文献

参考文献13

二级参考文献35

  • 1沈澄.健郎星[J].中南药学,2003,1(3):187-187. 被引量:1
  • 2焦效兰,於东晖,邹安庆,楼雅卿.高效液相色谱法测定人血清及尿中奥拉西坦的浓度[J].药学学报,1994,29(8):570-575. 被引量:15
  • 3[2]Son J,Lee J,Lee M,et al.Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry[J].J Pharm Biomed Anal.2004 Sep21;36(1):183-7
  • 4[4]Lecaillon JB,Souppart C,Le Duiqou F,et al.Determination of oxiracetam in plasma and urine by column-switching high performance liquid chram atography[J].J Chramatogr,1989,497(12):223-230.
  • 5[5]Perucca E,Alhrici A,Gatti G,et al.Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers[J].Eur J Drug Metab Pharmacokinet,1984,9(3):267-274.
  • 6[6]Richard CS,Venkata KB,Bruce YH,et al.Determination of oxiracetam in human plasma by reversed-phase high-performance liquid chromatography with fluorimetrie detection[J].Journal of Chromatography,1993,631(1-2):227-232.
  • 7[8]Visconti M,Spalluto R,Crolla T,et al.Determination of oxiracetam in human serum and urine by high-performance liquid chromatography[J].Journal of Chromatography,1987,416(1):433-438.
  • 8於毓文,药物代射研究.意义、方法、应用,1990年
  • 9Parnetti L, Mecocci P, Gaiti A, et al. Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type [J]. Eur J Drug Metab Pharmacokinet, 1990, 15(1): 75-78.
  • 10Ponzio F, Pozzi O, Banfi S, et al. Brain entry and direct central pharmacological effects of the nootropic drug oxiracetam. Oxiracetam: brain entry and pharmacological effects [J]. Pharmacopsychiatry, 1989, 22(Suppl 2): 111-115.

共引文献87

同被引文献26

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部